Van Hees T, Piel G, Evrard B, Otte X, Thunus L, Delattre L
Department of Pharmaceutical Technology, Institute of Pharmacy, University of Liege, Belgium.
Pharm Res. 1999 Dec;16(12):1864-70. doi: 10.1023/a:1018955410414.
Piroxicam is a poorly soluble NSAID, whose solubility is enhanced when included into beta-cyclodextrin. The preparation of a piroxicam-beta-cyclodextrin inclusion compound using supercritical CO2 was investigated.
The solubility and the stability of piroxicam in supercritical CO2 were determined. Then, the influence of the temperature, the pressure and the time of exposure on the inclusion rate was studied.
The solubility of piroxicam varied over a wide range depending on the temperature and pressure (from 0.006 to 1.500 mg/g of CO2). The temperature and the time of exposure had a great influence on the inclusion yield, while pressure did not and a complete inclusion was achieved by keeping a physical mixture of piroxicam and beta-cyclodextrin (1:2.5 mol/mol) for 6 hours at 150 degrees C and 15 MPa of CO2. This complex was characterized by Differential Scanning Calorimetry, differential solubility and Fourier Transform Infrared Spectrometry.
Supercritical carbon dioxide may prove to be a novel useful complexation method of drugs into beta-cyclodextrin.
吡罗昔康是一种难溶性非甾体抗炎药,当它被包合进β-环糊精时溶解度会提高。本研究探讨了使用超临界二氧化碳制备吡罗昔康-β-环糊精包合物的方法。
测定了吡罗昔康在超临界二氧化碳中的溶解度和稳定性。然后,研究了温度、压力和暴露时间对包合率的影响。
吡罗昔康的溶解度随温度和压力的变化范围很大(从0.006至1.500毫克/克二氧化碳)。温度和暴露时间对包合产率有很大影响,而压力则无影响,通过在150℃和15兆帕的二氧化碳条件下将吡罗昔康与β-环糊精的物理混合物(1:2.5摩尔/摩尔)保持6小时可实现完全包合。该复合物通过差示扫描量热法、差示溶解度法和傅里叶变换红外光谱法进行了表征。
超临界二氧化碳可能被证明是一种将药物包合进β-环糊精的新型有用的络合方法。